LY75 and melanoma: Related to this, we demonstrated that innate immune training with CTB followed by administration of antigen OVA targeted to DCs by anti-DEC205, protected mice against B16-OVA tumor growth and extended tumor-free survival time up to7 days, suggesting a protective role of DCs training in murine melanoma.